Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.

By S. Tonstad, P. Tønnesen, P. Hajek, K. Williams, C. Billing, K. Reeves. Journal of the American Medical Association (JAMA), 2006

673 citations recorded by the source corpus.

Subfields: Molecular Biology, Physiology

View Paper: https://www.semanticscholar.org/paper/23f38ec70d8cd21ab25ef3c2f3681e0c98d21ea2

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. N. Benowitz

Citations in the corpus

• Pharmacology of Nicotine: Addiction, Smoking-Induced Disease, and Therapeutics (2009, background): “Clinical trials have found that varenicline is superior to bupropion in promoting smoking cessation, and prolonged administration of varenicline has been shown to reduce relapse in smokers who were abstinent 12 weeks after initial therapy (80, 81).”
• 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014, background): “Tonstad 2006 (305) 16820548 Effect of varenicline on smoking cessation Multice nter Prospe ctive Study 1,210 Varencline 603 PC 607 18-75 y.”